0001615219-19-000039.txt : 20190913
0001615219-19-000039.hdr.sgml : 20190913
20190913061654
ACCESSION NUMBER: 0001615219-19-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190910
FILED AS OF DATE: 20190913
DATE AS OF CHANGE: 20190913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arthur David J.
CENTRAL INDEX KEY: 0001769331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 191091514
MAIL ADDRESS:
STREET 1: 2450 HOLCOME BLVD.
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_156836979901866.xml
FORM 4
X0306
4
2019-09-10
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001769331
Arthur David J.
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOME BLVD., SUITE J-608
HOUSTON
TX
77021
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
8.0
2019-09-10
4
A
0
30000
0
A
2029-09-10
Common Stock
30000.0
30000
D
The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter.
/s/ David J. Arthur
2019-09-10